Get started
Author

Timothy G Tyler

Observed names: T. Tyler, Timothy G. Tyler, Timothy Tyler, Timothy Tyler, PharmD, Timothy Tyler, PharmD, FCSHP
Observed institution: Desert Regional Medical Center
ORCID: 0009-0003-6208-4502
Observed ORCID: 0009-0003-6208-4502
OpenAlex ID: A5113785207
Reduction in surface contamination with antineoplastic drugs in 22 hospital pharmacies in the US following implementation of a closed-system drug transfer device
2010 · Paul JM Sessink, Thomas H Connor, et al. · Journal of Oncology Pharmacy Practice · 169
Multicenter evaluation of a new closed system drug-transfer device in reducing surface contamination by antineoplastic hazardous drugs
2018 · Sylvia B. Bartel, Timothy G. Tyler, et al. · American Journal of Health-System Pharmacy · 36
The Role of Cetirizine in the Changing Landscape of IV Antihistamines: A Narrative Review
2021 · Michael S. Blaiss, Jonathan A. Bernstein, et al. · Advances in Therapy · 34
PDF
How can the use of closed system transfer devices to facilitate sharing of drug vials be optimised to achieve maximum cost savings?
2018 · Peter J Gilbar, Carole R Chambers, et al. · Journal of Oncology Pharmacy Practice · 18
Axitinib: Newly Approved for Renal Cell Carcinoma
2012 · Timothy Tyler, PharmD, FCSHP · Journal of the Advanced Practitioner in Oncology · 18
PDF
Once-Daily Dasatinib for Treatment of Patients with Chronic Myeloid Leukemia
2009 · Timothy Tyler · Annals of Pharmacotherapy · 11
Drug interactions in metastatic breast cancer
2010 · Timothy Tyler · Journal of Oncology Pharmacy Practice · 10
Challenges in the Development of Intravenous Neurokinin‐1 Receptor Antagonists: Results of a Safety and Pharmacokinetics Dose‐Finding, Phase 1 Study of Intravenous Fosnetupitant
2022 · Timothy Tyler, Armin Schultz, et al. · Clinical Pharmacology in Drug Development · 8
PDF
Individual patient data meta-analysis of NEPA versus aprepitant-based antiemetic regimens for preventing chemotherapy-induced nausea and vomiting
2025 · Rudolph M. Navari, Timothy Tyler, et al. · Future Oncology · 3
Intravenous Cetirizine Premedication to Mitigate Infusion-Related Reactions
2024 · Timothy Tyler, PharmD, Erik Stojanoff, PharmD, et al. · Journal of the Advanced Practitioner in Oncology · 3
PDF
Abstract PS2-02-01: Improved Antiemetic Outcomes with NEPA vs (Fos)aprepitant in Patients with Breast Cancer Receiving Antibody-Drug Conjugates: A 12-Month Real-World Claims Analysis
2026 · L. Schwartzberg, T. Gillespie, et al. · Clinical Cancer Research
Abstract 4231: Significant reduction in workplace contamination of antineoplastic hazardous drugs in 13 U.S. hospitals following utilization of a new closed-system drug transfer device
2017 · Timothy Tyler, Luci Power · Cancer Research
Roundtable Review: Addressing Challenges in the Late-line Treatment of Multiple Myeloma
2012 · Timothy Tyler, PharmD, et al.
Challenges in the Treatment of Relapsed and/or Refractory Myeloma
2012 · Timothy Tyler, PharmD, et al.
Brother, Can You Spare Some Chemotherapy? No End in Sight for Drug Shortages
2011 · Timothy Tyler, PharmD, et al.
Ipilimumab: A New Era in Metastatic Melanoma Management
2011 · Timothy Tyler, PharmD, et al.
Infrastructure Issues in the US Drug Supply: Where Did the Drugs Go?
2011 · Timothy Tyler, PharmD, et al.
Optimizing Dasatinib Therapy for Patients with Chronic-phase CML
2010 · Timothy Tyler, PharmD, et al.
Works count: 18
Citation count: 310
H-index: 8
I10-index: 7
Year
Topic
Type